Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date: January 15, 2014
Event: Disclosure of presentation materials for the JP Morgan 32nd Annual Healthcare Conference.
Key Financial Metrics
This filing does not contain specific financial data. The document serves solely to disclose the existence of presentation slides (Exhibit 99.1) and explicitly states that the information within those slides is not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, no revenue, profit, cash flow, margin, debt, or liquidity figures are provided in this text.
Material Changes
No material changes to financial results or operations are reported in this filing. The document is a procedural disclosure regarding an investor presentation.
Guidance, Outlook, and Risks
Management Commentary: Joseph M. DeVivo, President and CEO, presented to investors at the JP Morgan Healthcare Conference.
Legal Status of Information: The presentation slides are furnished pursuant to Item 7.01 (Regulation FD Disclosure). The filing explicitly notes that the information in the slides shall not be deemed "filed" and is not incorporated by reference into other company filings under the Securities Act of 1933.
Investor Verification Checklist
- Verify the content of the presentation slides (Exhibit 99.1) separately, as they are not legally "filed" within this 8-K text.
- Review the company's most recent 10-K or 10-Q for actual audited or unaudited financial metrics, as this 8-K contains none.
- Confirm if any forward-looking statements made during the conference have been updated in subsequent filings.